https://www.selleckchem.com/products/gdc-0068.html
64, 95% confidence interval [CI] 1.43-4.89, = 0.002). This finding was similar in the ****tion cohort (OR 3.46, 95% CI 1.86-6.44, 0.001). The presence of NCCT hypodensities in patients with USO was an independent predictor of HE in the development (OR 2.59, 95% CI 1.27-5.28, = 0.009) and ****tion (OR 2.43, 95% CI 1.42-4.17, = 0.001) population. HE is common in patients with USO and independently associated with worse outcome. These findings suggest that patients with USO may be enrolled in clinical trials of medical treatmen
Like
Comment
Share
